Kobo Biotech Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, revenue was INR 0.152 million compared to INR 0.152 million a year ago. Net loss was INR 49.29 million compared to INR 55.53 million a year ago. Basic loss per share from continuing operations was INR 2.07 compared to INR 2.33 a year ago. Diluted loss per share from continuing operations was INR 2.07 compared to INR 2.33 a year ago.